Fig. 1 | Scientific Reports

Fig. 1

From: PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC

Fig. 1

Database analysis of PLAGL2 expression and role in PDAC. (A) GEPIA was used to analyze the differential expression of PLAGL2 in various tumors and corresponding normal tissues in the TCGA and GTEx database; (B) PDAC differential expression with normal pancreatic tissues; (C) PLAGL2 expression in PDAC with different stages;. (D) PLAGL2 related genes in the String database; (E) GO enrichment analysis of PLAGL2-related genes; (F) KEGG pathway enrichment analysis of PLAGL2-related genes; G and H: GSEA pathway enrichment analysis of PLAGL2-related genes;

Back to article page